Skip to main content

Want a detailed portfolio tracker?

Milestone Pharmaceuticals (MIST) P/E (2019 - 2026)

Milestone Pharmaceuticals (MIST) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Milestone Pharmaceuticals (MIST) P/E is -1.60. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Milestone Pharmaceuticals (MIST)

YearP/EChange
2026-1.60-25.86%
2025-2.16-28.68%
2024-3.03+220.10%
2023-0.95-50.59%
2022-1.92-58.05%
2021-4.57+34.04%
2020-3.41-61.09%
2019-8.76N/A

Comparison Milestone Pharmaceuticals (MIST) P/E with competitors

Milestone Pharmaceuticals (MIST) P/E is -1.60.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.11%
NBYStablecoin Development Corp0.00-100.27%
ENLVEnlivex Ltd0.07-104.67%
FGENFibroGen Inc0.24-114.98%
CHRSCoherus Biosciences Inc0.85-152.95%
FBIOFortress Biotech Inc0.95-159.22%
ORMPOramed Pharmaceuticals Inc1.50-193.80%
AGENAgenus Inc3.01-287.81%
INVAInnoviva Inc3.15-296.83%
VXRTVaxart Inc3.55-321.52%
CRMDCorMedix Inc3.63-326.43%
CVACCureVac N.V.4.45-377.43%
GLPGGalapagos NV4.86-403.22%
SRPTSarepta Therapeutics Inc4.88-404.67%
ABEOAbeona Therapeutics Inc5.39-436.21%
ABUSArbutus Biopharma Corp5.60-449.19%
ZVRAZevra Therapeutics Inc5.89-467.39%
SPROSpero Therapeutics Inc6.23-488.69%
CGENCompugen Ltd6.31-494.02%
RIGLRigel Pharmaceuticals6.87-528.85%
SLXNSilexion Therapeutics Corp7.30-555.31%
OMEROmeros Corporation9.26-677.79%
AUPHAurinia Pharmaceuticals Inc9.58-698.15%
PLXProtalix BioTherapeutics Inc10.89-779.65%
ACADAcadia Pharmaceuticals Inc11.73-831.92%
TBPHTheravance Biopharma Inc12.26-865.22%
ADMAAdma Biologics Inc12.42-874.96%
HRMYHarmony Biosciences Holdings Inc13.82-962.45%
SABSSAB Biotherapeutics Inc14.14-982.17%
NAGENiagen Bioscience Inc14.82-1024.73%
INCYIncyte Corp15.82-1087.41%
REGNRegeneron Pharmaceuticals Inc15.86-1089.54%
PBYIPuma Biotechnology Inc17.32-1180.59%
CPRXCatalyst Pharmaceuticals Inc17.44-1188.30%
EXELExelixis Inc17.54-1194.46%
TGTXTG Therapeutics Inc18.97-1283.58%
MDXGMimedx Group Inc20.55-1382.58%
XOMAXOMA Royalty Corp22.87-1527.54%
ARGXArgen X SE24.30-1616.36%
CTMXCytomX Therapeutics Inc24.82-1649.01%
XOMAOXOMA Royalty Corp25.34-1681.69%
HALOHalozyme Therapeutics Inc25.62-1699.09%
XOMAPXOMA Royalty Corp25.67-1701.99%
VRTXVertex Pharmaceuticals Inc27.99-1847.06%
RPRXRoyalty Pharma plc - Class A28.69-1890.30%
SLNOSoleno Therapeutics Inc29.02-1910.75%
ASNDAscendis Pharma A/S30.09-1977.54%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2465.97%
APLSApellis Pharmaceuticals Inc39.02-2535.19%
BMRNBiomarin Pharmaceutical Inc42.21-2734.31%
KRYSKrystal Biotech Inc45.34-2929.74%
ONCBeiGene Ltd69.54-4439.80%
PHARPharming Group N.V.75.03-4782.11%
TECHBio-Techne Corp101.96-6462.90%
VCELVericel Corp109.92-6959.84%
ALNYAlnylam Pharmaceuticals Inc117.96-7461.83%
GMABGenmab140.29-8855.10%
TLXTelix Pharmaceuticals Ltd162.15-10219.45%
CORTCorcept Therapeutics Inc212.86-13383.77%